Parmar, K.; Subramanyam, S.; Attwood, K.; Appiah, D.; Fountzilas, C.; Mukherjee, S.
Anti PD-1/Anti PDL-1 Inhibitors in Advanced Gastroesophageal Cancers: A Systematic Review and Meta-Analysis of Phase 2/3 Randomized Controlled Trials. Pharmaceutics 2022, 14, 1953.
https://doi.org/10.3390/pharmaceutics14091953
AMA Style
Parmar K, Subramanyam S, Attwood K, Appiah D, Fountzilas C, Mukherjee S.
Anti PD-1/Anti PDL-1 Inhibitors in Advanced Gastroesophageal Cancers: A Systematic Review and Meta-Analysis of Phase 2/3 Randomized Controlled Trials. Pharmaceutics. 2022; 14(9):1953.
https://doi.org/10.3390/pharmaceutics14091953
Chicago/Turabian Style
Parmar, Kanak, Sai Subramanyam, Kristopher Attwood, Duke Appiah, Christos Fountzilas, and Sarbajit Mukherjee.
2022. "Anti PD-1/Anti PDL-1 Inhibitors in Advanced Gastroesophageal Cancers: A Systematic Review and Meta-Analysis of Phase 2/3 Randomized Controlled Trials" Pharmaceutics 14, no. 9: 1953.
https://doi.org/10.3390/pharmaceutics14091953
APA Style
Parmar, K., Subramanyam, S., Attwood, K., Appiah, D., Fountzilas, C., & Mukherjee, S.
(2022). Anti PD-1/Anti PDL-1 Inhibitors in Advanced Gastroesophageal Cancers: A Systematic Review and Meta-Analysis of Phase 2/3 Randomized Controlled Trials. Pharmaceutics, 14(9), 1953.
https://doi.org/10.3390/pharmaceutics14091953